newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 4, 2025 / CASI Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class,